Management Options for Premature Ejaculation and Delayed Ejaculation in Men

Patrick Martin-Tuite, Alan W. Shindel

Research output: Contribution to journalReview article

Abstract

Introduction: Many men experience distressing issues regarding the timing of orgasm and ejaculation, such as premature ejaculation (PE) and delayed ejaculation (DE). Despite being highly prevalent, both PE and DE are poorly understood and present a management challenge for sexual medicine specialists. Aim: To summarize existing data on the medical management of PE and DE. Methods: A comprehensive literature review pertaining to the management of PE and DE was conducted using PubMed and clinicaltrials.gov for data published up until May 2019. Our focus was on double-blind, placebo-controlled trials and meta-analyses of such studies. Main Outcome Measure: Peer-reviewed studies on treatment options for PE and DE were critically analyzed for results and methodological rigor. Results: The peer-reviewed data on PE management continue to evolve. Psychotherapy, pharmacotherapy, and procedural interventions have all been associated with some degree of efficacy. A strong evidence base supports the off-label use of selective serotonin reuptake inhibitors and local anesthetics in PE given consistent increases in ejaculation latency time. Education and mental health assessments remain important components of PE management despite a dearth of peer-reviewed data on these interventions. Numerous treatment strategies have been evaluated for DE; limited data support psychotherapy, pharmacotherapy, and/or penile vibratory stimulation as management options. Conclusion: A number of management options for PE or DE exist but none has been formally approved by the US Food and Drug Administration. New and novel treatments would be of great value in managing issues regarding the timing of ejaculation/orgasm. Martin-Tuite P, Shindel AW. Management Options for Premature Ejaculation and Delayed Ejaculation in Men. Sex Med Rev 2019; XX:XXX–XXX.

Original languageEnglish (US)
JournalSexual Medicine Reviews
DOIs
StateAccepted/In press - Jan 1 2019

Fingerprint

Premature Ejaculation
Ejaculation
Orgasm
Psychotherapy
Off-Label Use
Drug Therapy
Serotonin Uptake Inhibitors
United States Food and Drug Administration
Local Anesthetics
PubMed
Meta-Analysis
Mental Health
Therapeutics

Keywords

  • Anorgasmia
  • Delayed Ejaculation
  • Pharmacotherapy of Delayed Ejaculation
  • Pharmacotherapy of Premature Ejaculation
  • Premature Ejaculation
  • Sexual Dysfunction

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynecology
  • Urology

Cite this

Management Options for Premature Ejaculation and Delayed Ejaculation in Men. / Martin-Tuite, Patrick; Shindel, Alan W.

In: Sexual Medicine Reviews, 01.01.2019.

Research output: Contribution to journalReview article

@article{dd41f1295a6848b799cd1d1418bd14bd,
title = "Management Options for Premature Ejaculation and Delayed Ejaculation in Men",
abstract = "Introduction: Many men experience distressing issues regarding the timing of orgasm and ejaculation, such as premature ejaculation (PE) and delayed ejaculation (DE). Despite being highly prevalent, both PE and DE are poorly understood and present a management challenge for sexual medicine specialists. Aim: To summarize existing data on the medical management of PE and DE. Methods: A comprehensive literature review pertaining to the management of PE and DE was conducted using PubMed and clinicaltrials.gov for data published up until May 2019. Our focus was on double-blind, placebo-controlled trials and meta-analyses of such studies. Main Outcome Measure: Peer-reviewed studies on treatment options for PE and DE were critically analyzed for results and methodological rigor. Results: The peer-reviewed data on PE management continue to evolve. Psychotherapy, pharmacotherapy, and procedural interventions have all been associated with some degree of efficacy. A strong evidence base supports the off-label use of selective serotonin reuptake inhibitors and local anesthetics in PE given consistent increases in ejaculation latency time. Education and mental health assessments remain important components of PE management despite a dearth of peer-reviewed data on these interventions. Numerous treatment strategies have been evaluated for DE; limited data support psychotherapy, pharmacotherapy, and/or penile vibratory stimulation as management options. Conclusion: A number of management options for PE or DE exist but none has been formally approved by the US Food and Drug Administration. New and novel treatments would be of great value in managing issues regarding the timing of ejaculation/orgasm. Martin-Tuite P, Shindel AW. Management Options for Premature Ejaculation and Delayed Ejaculation in Men. Sex Med Rev 2019; XX:XXX–XXX.",
keywords = "Anorgasmia, Delayed Ejaculation, Pharmacotherapy of Delayed Ejaculation, Pharmacotherapy of Premature Ejaculation, Premature Ejaculation, Sexual Dysfunction",
author = "Patrick Martin-Tuite and Shindel, {Alan W.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.sxmr.2019.09.002",
language = "English (US)",
journal = "Sexual Medicine Reviews",
issn = "2050-0513",
publisher = "John Wiley & Sons Inc.",

}

TY - JOUR

T1 - Management Options for Premature Ejaculation and Delayed Ejaculation in Men

AU - Martin-Tuite, Patrick

AU - Shindel, Alan W.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Introduction: Many men experience distressing issues regarding the timing of orgasm and ejaculation, such as premature ejaculation (PE) and delayed ejaculation (DE). Despite being highly prevalent, both PE and DE are poorly understood and present a management challenge for sexual medicine specialists. Aim: To summarize existing data on the medical management of PE and DE. Methods: A comprehensive literature review pertaining to the management of PE and DE was conducted using PubMed and clinicaltrials.gov for data published up until May 2019. Our focus was on double-blind, placebo-controlled trials and meta-analyses of such studies. Main Outcome Measure: Peer-reviewed studies on treatment options for PE and DE were critically analyzed for results and methodological rigor. Results: The peer-reviewed data on PE management continue to evolve. Psychotherapy, pharmacotherapy, and procedural interventions have all been associated with some degree of efficacy. A strong evidence base supports the off-label use of selective serotonin reuptake inhibitors and local anesthetics in PE given consistent increases in ejaculation latency time. Education and mental health assessments remain important components of PE management despite a dearth of peer-reviewed data on these interventions. Numerous treatment strategies have been evaluated for DE; limited data support psychotherapy, pharmacotherapy, and/or penile vibratory stimulation as management options. Conclusion: A number of management options for PE or DE exist but none has been formally approved by the US Food and Drug Administration. New and novel treatments would be of great value in managing issues regarding the timing of ejaculation/orgasm. Martin-Tuite P, Shindel AW. Management Options for Premature Ejaculation and Delayed Ejaculation in Men. Sex Med Rev 2019; XX:XXX–XXX.

AB - Introduction: Many men experience distressing issues regarding the timing of orgasm and ejaculation, such as premature ejaculation (PE) and delayed ejaculation (DE). Despite being highly prevalent, both PE and DE are poorly understood and present a management challenge for sexual medicine specialists. Aim: To summarize existing data on the medical management of PE and DE. Methods: A comprehensive literature review pertaining to the management of PE and DE was conducted using PubMed and clinicaltrials.gov for data published up until May 2019. Our focus was on double-blind, placebo-controlled trials and meta-analyses of such studies. Main Outcome Measure: Peer-reviewed studies on treatment options for PE and DE were critically analyzed for results and methodological rigor. Results: The peer-reviewed data on PE management continue to evolve. Psychotherapy, pharmacotherapy, and procedural interventions have all been associated with some degree of efficacy. A strong evidence base supports the off-label use of selective serotonin reuptake inhibitors and local anesthetics in PE given consistent increases in ejaculation latency time. Education and mental health assessments remain important components of PE management despite a dearth of peer-reviewed data on these interventions. Numerous treatment strategies have been evaluated for DE; limited data support psychotherapy, pharmacotherapy, and/or penile vibratory stimulation as management options. Conclusion: A number of management options for PE or DE exist but none has been formally approved by the US Food and Drug Administration. New and novel treatments would be of great value in managing issues regarding the timing of ejaculation/orgasm. Martin-Tuite P, Shindel AW. Management Options for Premature Ejaculation and Delayed Ejaculation in Men. Sex Med Rev 2019; XX:XXX–XXX.

KW - Anorgasmia

KW - Delayed Ejaculation

KW - Pharmacotherapy of Delayed Ejaculation

KW - Pharmacotherapy of Premature Ejaculation

KW - Premature Ejaculation

KW - Sexual Dysfunction

UR - http://www.scopus.com/inward/record.url?scp=85074485758&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074485758&partnerID=8YFLogxK

U2 - 10.1016/j.sxmr.2019.09.002

DO - 10.1016/j.sxmr.2019.09.002

M3 - Review article

C2 - 31668585

AN - SCOPUS:85074485758

JO - Sexual Medicine Reviews

JF - Sexual Medicine Reviews

SN - 2050-0513

ER -